Toronto Dominion Bank’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Toronto Dominion Bank’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,000	Closed	-$192K	–	1775
2024 Q4	$192K	Buy	+20,000	New	+$104K	﹤0.01%	1276
2022 Q2	–	Sell	-3	Closed	–	–	1981
2022 Q1	$0	Hold	3	–	–	﹤0.01%	2094
2021 Q4	$0	Buy	+3	New	+$20	﹤0.01%	2093

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Toronto Dominion Bank's PSTX Position: Q1 2025 in Review

Toronto Dominion Bank sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 20,000 shares — an estimated $192K sold.

Toronto Dominion Bank first reported a position in PSTX in Q4 2021 and held it in 3 quarters. The position peaked at $192K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Toronto Dominion Bank reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Toronto Dominion Bank sold 20,000 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $192K.
Toronto Dominion Bank first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Toronto Dominion Bank's Poseida Therapeutics, Inc. Common Stock position peaked at $192K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Toronto Dominion Bank's 13F filing for Q1 2025, filed 15 May 2025.